Higher Hemoglobin A1c After Discharge Is an Independent Predictor of Adverse Outcomes in Patients With Acute Coronary Syndrome - Findings From the PACIFIC Registry

Circ J. 2016 Jun 24;80(7):1607-14. doi: 10.1253/circj.CJ-15-1126. Epub 2016 May 19.

Abstract

Background: Optimal medical therapy (OMT) and the management of coronary risk factors are necessary for secondary prevention of major adverse cardiac and cerebrovascular events (MACCE) in post-acute coronary syndrome (ACS) patients. However, the effect of post-discharge patient adherence has not been investigated in Japanese patients.

Methods and results: The Prevention of AtherothrombotiC Incidents Following Ischemic Coronary Attack (PACIFIC) registry was a multicenter, prospective observational study of 3,597 patients with ACS. Death or MACCE occurred in 229 patients between hospitalization and up to 1 year after discharge. Among 2,587 patients, the association between OMT adherence and risk factor control at 1 year and MACCE occurring between 1 and 2 years after discharge was assessed. OMT was defined as the use of antiplatelet agents, angiotensin-converting enzyme inhibitors, β-blockers, and statins. Risk factor targets were: low-density lipoprotein-cholesterol <100 mg/dl, HbA1c <7.0%, non-smoking status, blood pressure <130/80 mmHg, and 18.5≤body mass index≤24.9 kg/m(2). The incidence of MACCE was 1.8% and associated with female sex (P=0.020), age ≥75 years (P=0.004), HbA1c ≥7.0% (P=0.004), LV ejection fraction <35% (P<0.001), estimated glomerular filtration rate <60 ml/min (P=0.008), and history of cerebral infarction (P=0.003). In multivariate analysis, lower post-discharge HbA1c was strongly associated with a lower risk of MACCE after ACS (P=0.004).

Conclusions: Hyperglycemia after discharge is a crucial target for the prevention of MACCE in post-ACS patients. (Circ J 2016; 80: 1607-1614).

Publication types

  • Clinical Trial
  • Multicenter Study
  • Observational Study

MeSH terms

  • Acute Coronary Syndrome* / blood
  • Acute Coronary Syndrome* / mortality
  • Acute Coronary Syndrome* / therapy
  • Adult
  • Aged
  • Aged, 80 and over
  • Cholesterol, LDL / blood
  • Female
  • Glycated Hemoglobin / metabolism*
  • Humans
  • Hyperglycemia / blood
  • Hyperglycemia / mortality
  • Hyperglycemia / therapy
  • Male
  • Middle Aged
  • Patient Discharge*
  • Registries*
  • Risk Factors
  • Sex Factors

Substances

  • Cholesterol, LDL
  • Glycated Hemoglobin A
  • hemoglobin A1c protein, human